Tumour specific reactions were demonstrated both in vivo and in vitro and these correlated significantly with the morphology and histology. The interpretation of the results for an individual is confounded by the multiplicity of factors influencing the outcome in a particular patient.
Summary.-Defects in cellular immunocompetence have been sought in 25 patients with Kaposi's sarcoma. Skin tests with recall antigens, and PHA lymphocyte stimulation in vitro showed that efferent delayed hypersensitivity responses are intact in the majority. However, attempted sensitization and subsequent challenge with DNCB demonstrated that the afferent limb of the responses was impaired in some patients. This did not appear to be related to the morphology of the tumour or to prognosis.
Tumour specific reactions were demonstrated both in vivo and in vitro and these correlated significantly with the morphology and histology. The interpretation of the results for an individual is confounded by the multiplicity of factors influencing the outcome in a particular patient. THE PIGMENTED haemangiosarcoma first described by Kaposi in 1872 is a rare malignant tumour, more prevalent in equatorial Africa than in temperate areas of the world. Though the restricted geographical distribution may indicate an inherited susceptibility to the tumour, it is of interest that herpesviruses have been located in long-term cultures of the sarcoma. Their relevance to the aetiology is as yet uncertain (Giraldo, Beth and Haguenau, 1972) . In adults, the disease is primarily cutaneous but in children it involves the lymph nodes, skin lesions being uncommon (U.I.C.C., 1962) .
The natural history of the disease is variable and correlates with the gross morphology and histology of the skin tumour (Taylor et al., 1971a) . Small nodules are relatively benign and may show spontaneous regression and disappear (Lothe, 1963) . Florid tumours are exophytic and lack skin cover whereas infiltrative lesions penetrate deeper tissues and are associated with dense fibrosis, but both are more aggressive than nodular disease. The lymphadenopathic form is disseminated and rapidly fatal. (U.I.C.C., 1968) . For subsequent therapy, the patients were randomized as described by Vogel et al. (1971) . The clinical and research investigations were all approved by a committee at Makerere University Medical School.
Preparation of cell extracts-.Sterile techniques were used throughout. Tumour tissue was obtained at the time of diagnostic biopsy. Where possible, an area of tumourfree skin was excised for preparation of the control extract, obtained as described by Taylor et al. (1971b) but lymphocytes were used if sufficient skin was not available. The method used to prepare the extracts has been described in detail by Fass, Herberman and Zeigler (1970) . Cell suspensions were obtained by mincing the tissue and cells disrupted by freezing, and subsequent exposure to saline solutions of decreasing tonicity. After each hypotonic lysis, the suspension was centrifuged and the supernatant fluid collected and pooled. This was then concentrated over a 36-h period by pressure dialysis at 4°C to a final volume of 1 ml. Following preparation, the protein concentration of the extracts was determined by the method of Lowry et al. (1951) . The extracts were made up to 3 protein concentrations (1 mg/ml, 0 5 mg/nil and 0-1 mg/ml) divided into 1 ml aliquots in tuberculin syringes and stored at -70°C until testing. The preparations were checked for bacteriological contamination by blood agar culture before testing.
Administration and interpretation of the skin tests.-Initial skin tests were undertaken before chemotherapy. 0-1 ml of the following antigens was injected intradermally in that area of the back between the scapulae: autologous tumour extract (ATE) and control skin extract ( Delayed hypersensitivity to DCNB (1-chloro-2,4-dinitrobenzene, Eastman Chemicals, New York) was tested using a 2000 ,ug sensitizing dose, which was allowed to evaporate within a 2 cm diameter polyethylene ring applied to the right forearm. The area had been previously cleaned with acetone and was subsequently covered by an occlusive dressing. Fourteen days later, a 100 ttg challenge was applied to another site. This was examined at 48 h and counted as positive if induration, vesicles and bullae were present.
Lymphocyte transformation by PHA and tumour cells. Lymphocytes were cultured from a sub-sample of the patients selected only by availability of sufficient blood or Bacteria were cultured from a number of the primary tumours, but the ATE and ASE were sterile in the 25 patients listed in Table I . In a further 2 patients, blood agar culture revealed bacterial contamination and these were excluded from the study. No immediate skin reactions were noted, the induration being maximal at 48 h. Positive responses were maximal at the 1 0 mg/ml injection site, with the exception of that of patient No. 14, in whom the 0 5 mg/ml site had the greater diameter. Eight of 24 patients showed positive results to ATE (Table II) . Seven of these were in patients with nodular or infiltrative tumours but the frequency was significantly lower in those with florid or lymphadenopathic lesions (P < 0-025, Fischer's exact test). There was also correlation with the histology of the tumour (Table III) , the incidence of positive results being greatest in those whose tumours had a mixed cell pattern. The duration of symptoms was greater than a year in those with positive response to ATE and all improved after chemotherapy. No correlation is seen between positive responses to ATE skin tests and in vitro tumour induced transformation. However, in 4 of those with positive ATE responses, the tumour nodules were too small to provide sufficient cells for both tests.
Only one patient (No. 9) with a florid tumour showed a positive response to ATE and on admission lymphocyte transformation was negative. His tumour responded completely to chemotherapy and he was re-tested on remission. The ATE skin test was positive, as was PHA induced transformation (ratio 129) and transformation induced by the ATE used for skin test (ratio 1-6). DISCUSSION Kaposi's sarcoma, in the majority of adult Africans, is a distinctive clinical entity but the tumour morphology may be variable. Tedeschi (1958) believed that a tumour changed its appearance as the disease progressed, but Reynolds, Winkelmann and Soule (1965) described many cutaneous forms and implied that each retained its integrity during the course of the disease. This concept was confirmed by Taylor et al. (1971a) , who found that differing histological patterns correlated with the tumour morphology (Table IV) . Nevertheless, histological differences were inadequate to explain the variable outcome. " Benign " nodules and the fatal lymphadenopathic form of the disease both have a mixed cell histopathology. The differing prognoses could be explained by variation either of tumour cell antigens or of the host response.
In the present study, the majority of patients were able to exhibit delayed hypersensitivity recall responses when challenged with bacterial antigens. Only one patient with an advanced florid tumour was unresponsive to all antigens and to DNCB sensitization. This contrasts with the findings of Solowey and Rappaport (1965) some degree the extent of reactivity to recall antigens. As DNCB testing invoIx es both the afferent and effector immune processes, it appears that non-reactive patients lack the capacity to be sensitized to the synthetic antigen. It is not known whether such a defect leads to, or results from, dlevelopment of the tumour, and Kaposi's sarcoma has been reported following immunosuppressive therapy (Siegel et al., 1969 This study adds Kaposi's sarcoma to the growing list of human tumours in which it is possible to demonstrate specific cell mediated immunity by cutaneous reactivity to ATE. The majority of these responses were evident in patients with indolent tumours, and were invariably associated with favourable responses of the tumour to chemotherapy. However, occasional responses to ATE were seen in patients with florid or infiltrative tumours. This implies that the lack of reactivity in the majority of patients with these aggressive tumours is not entirely due to 317 lack of antigens. It may, however, reflect the interaction of humeral and cellular immune mechanisms, a blocking factor protecting the tumour from the cellular immune response. A search for such antibodies would be a logical extension of this study of patients with Kaposi's sarconma.
